Lasmiditan hydrochloride

CAS No. 613677-28-4

Lasmiditan hydrochloride ( LY 573144 hydrochloride ;COL-144 hydrochloride )

Catalog No. M21603 CAS No. 613677-28-4

Lasmiditan hydrochloride is a novel centrally acting highly selective 5-HT(1F) receptor agonist (K1:2.21 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 70 Get Quote
5MG 99 Get Quote
10MG 148 Get Quote
25MG 267 Get Quote
50MG 400 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lasmiditan hydrochloride
  • Note
    Research use only not for human use.
  • Brief Description
    Lasmiditan hydrochloride is a novel centrally acting highly selective 5-HT(1F) receptor agonist (K1:2.21 μM).
  • Description
    Lasmiditan hydrochloride is a novel centrally acting highly selective 5-HT(1F) receptor agonist (K1:2.21 μM)?.
  • Synonyms
    LY 573144 hydrochloride ;COL-144 hydrochloride
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT
  • Research Area
    Neurological Disease
  • Indication
    Acute Migraine

Chemical Information

  • CAS Number
    613677-28-4
  • Formula Weight
    413.82
  • Molecular Formula
    C19H19ClF3N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:28 mg/mL (67.66 mM)
  • SMILES
    Cl.CN1CCC(CC1)C(=O)c1cccc(NC(=O)c2c(F)cc(F)cc2F)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Matilde Capi Fernando de Andrés Luana Lionetto. Lasmiditan for the Treatment of Migraine.Expert Opin Investig Drugs. 2017 Feb;26(2):227-234.
molnova catalog
related products
  • Aniracetam

    Aniracetam(Ro 13-5057) is a nootropics and neuroprotective drug, which is selectively modulates the AMPA receptor and nAChR.

  • Nelotanserin

    A potent, selective 5-HT2A inverse agonist with pKi of 9.2; displays >30- and 5000-fold selectivity compared with 5-HT2C and 5-HT2B receptors.

  • PF-05212377

    PF-05212377 (SAM-760, PF 5212377) is a potent and selective 5-HT6 receptor antagonist with potential therapy for the symptomatic treatment of mild to moderate Alzheimer's disease.